Exploring the potential anti-Alzheimer disease mechanisms of Alpiniae Oxyphyliae Fructus by network pharmacology study and molecular docking
暂无分享,去创建一个
Lei Chen | Bing Hu | Lei Chen | Mingyu Ding | Chao Gu | Xiao Peng | Yan Qu | Rong-Rong Zhen | Rong-Rong Zhen | Yan-Jie Qu | Li-Min Zhang | Hong-Mei An | B. Hu | Li-Min Zhang
[1] Yingying Pan,et al. Progress and Prospects of Research Ideas and Methods in the Network Pharmacology of Traditional Chinese Medicine. , 2022, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[2] P. Gold,et al. The PPARg System in Major Depression: Pathophysiologic and Therapeutic Implications , 2021, International journal of molecular sciences.
[3] Zhi Sun,et al. Alpiniae oxyphyllae Fructus and Alzheimer's disease: An update and current perspective on this traditional Chinese medicine. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[4] M. Islam,et al. Modulatory effect of ursolic acid on neurodegenerative activities in oxidative brain injury: An ex vivo study. , 2020, Journal of food biochemistry.
[5] S. Chinnathambi,et al. α-Linolenic acid inhibits tau aggregation and modulates tau conformation. , 2020, International journal of biological macromolecules.
[6] W. Bik,et al. The Effects of Alpha-Linolenic Acid on the Secretory Activity of Astrocytes and β Amyloid-Associated Neurodegeneration in Differentiated SH-SY5Y Cells: Alpha-Linolenic Acid Protects the SH-SY5Y cells against β Amyloid Toxicity , 2020, Oxidative medicine and cellular longevity.
[7] S. Nabavi,et al. MAP KINASE SIGNALING AS THERAPEUTIC TARGET FOR NEURODEGENERATION. , 2020, Pharmacological research.
[8] M. Shivakumar,et al. Antioxidant and Antiproliferative Potential of Bioactive Molecules Ursolic Acid and Thujone Isolated from Memecylon edule and Elaeagnus indica and Their Inhibitory Effect on Topoisomerase II by Molecular Docking Approach , 2020, BioMed research international.
[9] Xue Xiao,et al. Network Pharmacology in Research of Chinese Medicine Formula: Methodology, Application and Prospective , 2020, Chinese journal of integrative medicine.
[10] Blaine H M Mooers,et al. Shortcuts for faster image creation in PyMOL , 2019, Protein science : a publication of the Protein Society.
[11] R. Brinton,et al. Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer’s Mouse Model , 2019, Neurotherapeutics.
[12] A. F. Furian,et al. Chrysin protects against behavioral, cognitive and neurochemical alterations in a 6-hydroxydopamine model of Parkinson's disease , 2019, Neuroscience Letters.
[13] S. Shui,et al. Chrysin ameliorates cerebral ischemia/reperfusion (I/R) injury in rats by regulating the PI3K/Akt/mTOR pathway , 2019, Neurochemistry International.
[14] Olivier Michielin,et al. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..
[15] J. Brigman,et al. Genetic inactivation of hypoxia inducible factor 1-alpha (HIF-1α) in adult hippocampal progenitors impairs neurogenesis and pattern discrimination learning , 2019, Neurobiology of Learning and Memory.
[16] Wei Chen,et al. TGF-β1 Restores Hippocampal Synaptic Plasticity and Memory in Alzheimer Model via the PI3K/Akt/Wnt/β-Catenin Signaling Pathway , 2018, Journal of Molecular Neuroscience.
[17] Wei Zhang,et al. ETCM: an encyclopaedia of traditional Chinese medicine , 2018, Nucleic Acids Res..
[18] David S. Goodsell,et al. RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy , 2018, Nucleic Acids Res..
[19] P. Hof,et al. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer’s disease , 2018, Progress in Neurobiology.
[20] J. Haines,et al. Alzheimer Disease: Perspectives from Epidemiology and Genetics , 2018, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.
[21] Kaishun Bi,et al. Protective effects of Alpinae Oxyphyllae Fructus extracts on lipopolysaccharide-induced animal model of Alzheimer's disease. , 2018, Journal of ethnopharmacology.
[22] D. Bennett,et al. Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease , 2017, Antioxidants & redox signaling.
[23] Ming Chen,et al. Inhibitory effect of verbascoside on xanthine oxidase activity. , 2016, International journal of biological macromolecules.
[24] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[25] Jung-Hye Choi,et al. Isocyperol, isolated from the rhizomes of Cyperus rotundus, inhibits LPS-induced inflammatory responses via suppression of the NF-κB and STAT3 pathways and ROS stress in LPS-stimulated RAW 264.7 cells. , 2016, International immunopharmacology.
[26] Alzheimer’s Association,et al. 2016 Alzheimer's disease facts and figures , 2016, Alzheimer's & Dementia.
[27] M. David,et al. Neuroprotective Effect of Nanodiamond in Alzheimer’s Disease Rat Model: a Pivotal Role for Modulating NF-κB and STAT3 Signaling , 2016, Molecular Neurobiology.
[28] Damian Szklarczyk,et al. STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data , 2015, Nucleic Acids Res..
[29] John J. Irwin,et al. ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..
[30] Gary D Bader,et al. Biological Network Exploration with Cytoscape 3 , 2014, Current protocols in bioinformatics.
[31] Wei Zhou,et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.
[32] Shao Li,et al. Traditional Chinese medicine network pharmacology: theory, methodology and application. , 2013, Chinese journal of natural medicines.
[33] W. Klein,et al. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease , 2011, Neurobiology of Learning and Memory.
[34] E. Boerwinkle,et al. Mining gold dust under the genome wide significance level: a two‐stage approach to analysis of GWAS , 2011, Genetic epidemiology.
[35] Tsviya Olender,et al. GeneCards Version 3: the human gene integrator , 2010, Database J. Biol. Databases Curation.
[36] A. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[37] Christian von Mering,et al. STITCH: interaction networks of chemicals and proteins , 2007, Nucleic Acids Res..
[38] I Ferrer,et al. N-myc and c-myc expression in Alzheimer disease, Huntington disease and Parkinson disease. , 2000, Brain research. Molecular brain research.
[39] David Satcher. Alzheimer’s Association , 2020, The Grants Register 2022.
[40] Haruki Nakamura,et al. Protein Data Bank (PDB): The Single Global Macromolecular Structure Archive. , 2017, Methods in molecular biology.
[41] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[42] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[43] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.